Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

pembrolizumab 2nilotinib 2avapritinib 2trastuzumab deruxtecan 1talquetamab 1pomalidomide 1montelukast 1lazertinib 1larotrectinib 1ivosidenib 1entrectinib 1dostarlimab 1daratumumab 1carfilzomib 1asciminib 1amivantamab 1Thalidomide 1TIC10 compound 1Prednisone 1Pemetrexed 1Melphalan 1Lenalidomide 1Imatinib Mesylate 1Diphenhydramine 1Dexamethasone 1Dasatinib 1Crizotinib 1Carboplatin 1Bortezomib 1Appointments and Schedules 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Has announcements × TIC10 compound × Clear all
NCT03416530 2025-02-14

ONC201 in Pediatric H3 K27M Gliomas

Jazz Pharmaceuticals

Phase 1 Terminated
134 enrolled 1 FDA
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡